PRIX GALIEN FRANCE

The Prix Galien France celebrates therapeutic excellence, it is a prize of great prestige, recognized by the public authorities, prized by researchers and health actors, it has existed since 1970 and rewards innovation in health.

It was France who took the initiative to create in 1970 a prize for pharmaceutical research whose notoriety and influence have since made it the greatest distinction in the world in this field: the Prix Galien.

The 2024 Awards Ceremony took place this last December 12 at the Val de Grȃce, Paris

Best Program for Patients

Association Les Cahutes de Louise
Hut respite stays for sick children and their families in an exceptional location

Best Medical Research

Dr Alexandre Puissant
MMAAD team (Molecular Mechanisms of Acute Myeloid Leukemia Development)

Best Pharmaceutical Product

OPZELURA^®
Incyte Biosciences France

CAMZYOS^®
Bristol Myers Squibb

Best Digital Health Solution

pOpmètre^®
Axelife

AIRGENIOUS™
Linde Homecare France

The Prix Galien distinguishes remarkable, recent and publicly available health innovations (all treatments combined) as well as emblematic research work. It therefore contributes, in particular, to promoting and energizing health research and encouraging the laboratories and teams that advance it. It honors exceptional innovations in all areas of health: drugs, medical devices, e-health and also patient support.

The interest shown in it by the public authorities, in particular the Ministers of Health, Research or Industry, as well as its audience abroad, encourages the teams to mobilize ever more to obtain this distinction.

If the prestige of the Prix Galien has accumulated over the years, it is thanks to the members of the various juries, which include eminent experts and specialists in each category. Through their choice of laureates, they have been able to faithfully endorse the therapeutic movement in France for more than half a century and highlight innovations and the most successful teams. The notoriety of the members of the jury, their scientific rigour, their independence, a license to assert with the health sector and public authorities the institutional nature of the Galien prize. It has for many years been taken as an example beyond the borders of our country.